Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.01 AUD | -1.16% | -5.07% | +50.50% |
Nov. 15 | Xero Poised for More Upside After 'Strong' Fiscal H1 Results, Jarden Research Says | MT |
Nov. 15 | Jarden Research Adjusts Xero's Price Target to AU$177 from AU$151, Keeps at Overweight | MT |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 696M | 828M | 1.05B | 1.33B | 1.63B | |||||
Other Revenues, Total | 22.01M | 20.68M | 47.2M | 73.61M | 83.01M | |||||
Total Revenues | 718M | 849M | 1.1B | 1.4B | 1.71B | |||||
Cost of Goods Sold, Total | 107M | 119M | 139M | 178M | 203M | |||||
Gross Profit | 612M | 730M | 957M | 1.22B | 1.51B | |||||
Selling General & Admin Expenses, Total | 402M | 414M | 547M | 640M | 726M | |||||
R&D Expenses | 178M | 250M | 372M | 490M | 526M | |||||
Other Operating Expenses | -2.85M | 4.38M | 7.79M | - | - | |||||
Other Operating Expenses, Total | 577M | 668M | 927M | 1.13B | 1.25B | |||||
Operating Income | 34.41M | 61.69M | 30.3M | 91.98M | 259M | |||||
Interest Expense, Total | -34.31M | -33.62M | -36.1M | -42.8M | -44.51M | |||||
Interest And Investment Income | 13.43M | 5.16M | 4.08M | 29.12M | 67.48M | |||||
Net Interest Expenses | -20.88M | -28.46M | -32.02M | -13.68M | 22.97M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -1.96M | -9.99M | -2.47M | -4.54M | 8.4M | |||||
EBT, Excl. Unusual Items | 11.56M | 23.23M | -4.2M | 73.77M | 290M | |||||
Restructuring Charges | - | - | - | -34.69M | -3.01M | |||||
Merger & Related Restructuring Charges | - | - | -2.5M | - | - | |||||
Impairment of Goodwill | - | - | -20.38M | -94.9M | - | |||||
Asset Writedown | -1.43M | - | -4.31M | -27.78M | -24.48M | |||||
Other Unusual Items | -300K | -67.17M | 33.76M | 7.93M | -685K | |||||
EBT, Incl. Unusual Items | 9.84M | -43.94M | 2.36M | -75.68M | 262M | |||||
Income Tax Expense | 6.5M | -63.71M | 11.48M | 37.86M | 87.27M | |||||
Earnings From Continuing Operations | 3.34M | 19.77M | -9.11M | -114M | 175M | |||||
Net Income to Company | 3.34M | 19.77M | -9.11M | -114M | 175M | |||||
Net Income - (IS) | 3.34M | 19.77M | -9.11M | -114M | 175M | |||||
Preferred Dividend and Other Adjustments | 44K | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 3.29M | 19.77M | -9.11M | -114M | 175M | |||||
Net Income to Common Excl. Extra Items | 3.29M | 19.77M | -9.11M | -114M | 175M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.02 | 0.14 | -0.06 | -0.76 | 1.15 | |||||
Basic EPS - Continuing Operations | 0.02 | 0.14 | -0.06 | -0.76 | 1.15 | |||||
Basic Weighted Average Shares Outstanding | 141M | 144M | 148M | 150M | 151M | |||||
Net EPS - Diluted | 0.02 | -2.66 | -0.06 | -0.76 | 1.14 | |||||
Diluted EPS - Continuing Operations | 0.02 | -2.66 | -0.06 | -0.76 | 1.14 | |||||
Diluted Weighted Average Shares Outstanding | 143M | 150M | 150M | 150M | 153M | |||||
Normalized Basic EPS | 0.05 | 0.1 | -0.02 | 0.31 | 1.2 | |||||
Normalized Diluted EPS | 0.05 | 0.1 | -0.02 | 0.31 | 1.19 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 46.47M | 73.61M | 44.22M | 106M | 272M | |||||
EBITA | 36.05M | 63.79M | 33.23M | 95.04M | 262M | |||||
EBIT | 34.41M | 61.69M | 30.3M | 91.98M | 259M | |||||
EBITDAR | 52.24M | 79.68M | 53.5M | 115M | 281M | |||||
Total Revenues (As Reported) | 718M | 849M | 1.1B | 1.4B | 1.71B | |||||
Effective Tax Rate - (Ratio) | 66.09 | 145.01 | 485.7 | -50.02 | 33.32 | |||||
Total Current Taxes | 9.2M | 9.41M | 10.09M | 35.46M | 26.06M | |||||
Total Deferred Taxes | -2.54M | -16.33M | 20.74M | 2.4M | 61.21M | |||||
Normalized Net Income | 7.23M | 14.52M | -2.63M | 46.1M | 181M | |||||
Interest on Long-Term Debt | 34.31M | 33.62M | 41.22M | 42.8M | 44.51M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 113M | 92.59M | 145M | 167M | 240M | |||||
Selling and Marketing Expenses | 313M | 308M | 406M | 472M | 541M | |||||
General and Administrative Expenses | 88.98M | 106M | 142M | 168M | 185M | |||||
Research And Development Expense From Footnotes | 194M | 266M | 389M | 530M | 578M | |||||
Net Rental Expense, Total | 5.77M | 6.07M | 9.28M | 9.4M | 9.04M | |||||
Imputed Operating Lease Interest Expense | 3.38M | 2.26M | 2.72M | 2.97M | 2.72M | |||||
Imputed Operating Lease Depreciation | 2.39M | 3.82M | 6.56M | 6.42M | 6.32M | |||||
Stock-Based Comp., Other (Total) | 34.34M | 42.73M | 61.06M | 80.86M | 95.82M | |||||
Total Stock-Based Compensation | 34.34M | 42.73M | 61.06M | 80.86M | 95.82M |